<?xml version="1.0" encoding="UTF-8"?>
<p>In India, the Ayurveda Practitioners are following suit by working on setting clear protocols with a rationale consistent with their millenary system. The first line of defense recommended to early-stage patients consists of the following herbal medicines: 
 <italic>Tinospora cordifolia</italic> (Willd.) Myers (Menispermaceae), 
 <italic>Zingiber officinale</italic> Roscoe (Zingiberaceae), 
 <italic>Curcuma longa</italic> L. (Zingiberaceae), 
 <italic>Ocimum sanctum</italic> L. (Lamiaceae), 
 <italic>Glycyrrhiza glabra</italic> L. (Fabaceae), 
 <italic>Adhatoda vasica</italic> Ness (Acanthaceae), (Acanthaceae), 
 <italic>Andrographis paniculata</italic> (Burm.f.) (Acanthaceae)
 <italic>, Swertia chirata</italic> Buch.-Ham. ex Wall. (Gentianaceae), 
 <italic>Moringa oleifera</italic> Lam (Moringaceae), Triphala [a mixture of the dried fruits of 
 <italic>Emblica officinalis</italic> Gaertn. (Phyllanthaceae)
 <italic>, Terminalia bellirica</italic> (Gaertn.) Roxb. (Combretaceae), and 
 <italic>Terminalia chebula</italic> Retz.(Combretaceae)] and Trikatu [a complementary formula to Triphala, including 
 <italic>Piper nigrum</italic> L. (Piperaceae)
 <italic>, Piper longum</italic> L. (Piperaceae), and 
 <italic>Z. officinale</italic> Roscoe] (
 <xref rid="B406" ref-type="bibr">Rastogi et al., 2020</xref>). Clinical settings and regulations of research on COVID-19 through Ayurveda, Unani, Siddha, and Homeopathy systems have already been published by the Indian Ministry of Ayush (
 <xref rid="B248" ref-type="bibr">INDIA, 2020</xref>).
</p>
